FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 12, Issue -, Pages 9857-9867
Publisher
Informa UK Limited
Online
2020-10-09
DOI
10.2147/cmar.s270825
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
- (2018) Shang Yao et al. SEMINARS IN CANCER BIOLOGY
- Regulation of the master regulator FOXM1 in cancer
- (2018) Guo-Bin Liao et al. Cell Communication and Signaling
- Progress in the chemotherapeutic treatment of osteosarcoma (Review)
- (2018) Ya Zhang et al. Oncology Letters
- FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression
- (2018) Yuzhen Zhou et al. CELL PROLIFERATION
- MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1
- (2018) Wei Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
- (2018) Kitti Intuyod et al. Cell Death & Disease
- FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis
- (2017) Yan Chen et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- FoxM1: Repurposing an oncogene as a biomarker
- (2017) Deeptashree Nandi et al. SEMINARS IN CANCER BIOLOGY
- O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway
- (2016) C M Ferrer et al. ONCOGENE
- FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways
- (2016) Fergal C. Kelleher et al. Oncotarget
- FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs
- (2015) FRANCESCA CONSOLARO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
- (2015) Michael S. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target
- (2015) Masaaki Kuda et al. TUMOR BIOLOGY
- FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
- (2014) Stefania Zona et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- β-catenin is a valuable marker for differential diagnosis of osteoblastoma and osteosarcoma
- (2014) Yang Wan et al. HUMAN PATHOLOGY
- FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
- (2013) Laura Christensen et al. PLoS One
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
- (2011) Lars Anders et al. CANCER CELL
- A Novel FoxM1-Caveolin Signaling Pathway Promotes Pancreatic Cancer Invasion and Metastasis
- (2011) C. Huang et al. CANCER RESEARCH
- Expression of FoxM1 Is Required for the Proliferation of Medulloblastoma Cells and Indicates Worse Survival of Patients
- (2011) M. Priller et al. CLINICAL CANCER RESEARCH
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
- (2008) J. M-M. Kwok et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started